SCHEMBL25516759

SCHEMBL25516759

c1ccc2c(c1)oc1ccc(N(c3ccc4c(ccc5oc6ccccc6c54)c3)c3ccc4sc5ccccc5c4c3)cc12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
GPR3 P46089 1/20 0.33
AHR P35869 2/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
NQO1 P15559 1/20 0.30
NQO2 P16083 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25516757 0.98 TDP1 (0.37) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25871843 0.96 AHR (0.35) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25871845 0.96 MAPT (0.36) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25516307 0.96 ALDH1A1 (0.36) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25872031 0.94 TDP1 (0.35) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL25516755 0.93 MAPT (0.37) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25871846 0.93 MAPT (0.39) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25883942 0.92 MAPT (0.35) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25883824 0.92 MAPT (0.36) MAPTALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL25516508 0.92 MAPT (0.36) MAPTALDH1A1HPGDSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 US disclosed
WO-2023085881-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR MAPT 2757/4885ALDH1A1 182/4885HPGD 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.